Data gathered: December 4
Data Bits
Data Bits | Value / Change | Benchmark | |
---|---|---|---|
Job Posts | 31 3.3% |
|
|
Sentiment | 57 0% |
|
|
Webpage traffic | 22,000 -4.4% |
|
|
Employee Rating | 91 0% |
|
|
Google Adspend | $18 -55% |
|
|
Google Trends | 7 -65% |
|
|
Linkedin Employees | 1,328 N/A |
|
|
Patents | 119 0% |
|
|
4chan Mentions | 0% |
|
|
Facebook Engagement | 334 0.9% |
|
|
Facebook followers | 8,971 0% |
|
|
Stocktwits Mentions | 5 0% |
|
|
Stocktwits Subscribers | 18,580 0% |
|
|
Twitter Followers | 5,264 0% |
|
|
Instagram Followers | 4,279 -0% |
|
|
News Mentions | 0% |
|
|
Reddit Mentions | 0% |
|
|
Business outlook | 93 0% |
|
In the news
Sarepta Therapeutics (SRPT) Up 4.5% Since Last Earnings Report: Can It Continue?December 1 - Yahoo |
|
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)November 30 - Yahoo |
|
Wall Street Analysts Think Sarepta Therapeutics (SRPT) Could Surge 82.64%: Read This Before Placing a BetNovember 28 - Yahoo |
|
When Will Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Turn A Profit?November 28 - Yahoo |
|
11 Best Upside Stocks To Buy Right NowNovember 26 - Yahoo |
|
13 Stocks Insiders are Buying NowNovember 23 - Yahoo |
About Sarepta Therapeutics
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Price | $83.33 |
Target Price | Sign up |
Market Cap | $7.9B |
Dividend Yield | 0.0126 |
Industry | Biotechnology |
Similar companies
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
---|---|---|---|---|---|
Q3 '23 | 332M | 149M | 183M | -41M | -28M |
Q2 '23 | 261M | 119M | 142M | -24M | -9.2M |
Q1 '23 | 254M | 111M | 143M | -517M | -506M |
Q4 '22 | 258M | 123M | 135M | -109M | -94M |
Q3 '22 | 230M | 105M | 125M | -258M | -242M |
Insider Transactions
INGRAM DOUGLAS S filed to buy 390,307 shares at $81.3. November 6 '23 |
Barry Richard filed to buy 140,000 shares at $78.8. November 6 '23 |
Chambers Michael Andrew filed to buy 246,996 shares at $109.9. August 15 '23 |
Chambers Michael Andrew filed to buy 237,017 shares at $108.1. August 14 '23 |
Chambers Michael Andrew filed to buy 213,331 shares at $106.3. August 11 '23 |